Therapeutic Potential of Amiloride Analogues in Cancer Treatment
Author Information
Author(s): R.P. Maidorn, E. J. Cragoe, Jr, I.F. Tannock
Primary Institution: Ontario Cancer Institute, University of Toronto
Hypothesis
Can amiloride analogues selectively kill tumor cells by inhibiting intracellular pH regulation?
Conclusion
Amiloride analogues EIPA, MIBA, and DMA enhance the toxicity of nigericin in acidic environments, suggesting potential for tumor-selective therapy.
Supporting Evidence
- EIPA and MIBA were found to be 200-fold and 100-fold more potent than amiloride in inhibiting the Na+/H+ antiport.
- Cell killing was significantly enhanced when EIPA or MIBA were used with nigericin at low pHe.
- Preliminary experiments suggested that EIPA and nigericin could enhance the toxicity of radiation in vivo.
Takeaway
This study shows that certain drugs can help kill cancer cells by making their insides more acidic, especially when combined with another drug that also lowers pH.
Methodology
The study involved testing the effects of amiloride analogues on cell lines and spheroids, measuring their ability to inhibit the Na+/H+ antiport and induce cell death in acidic conditions.
Limitations
Preliminary in vivo experiments were limited due to the availability of amiloride analogues.
Statistical Information
Confidence Interval
95% confidence intervals
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website